Filing status
- Accounts due
- 30 September 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 12 March 2027
- Last conf. stmt
- 26 February 2026
Cambridge Clinical Laboratories Ltd
- Incorporated
- 3 March 2005 (21 years)
- Previously known as
- Lab 21 Limited (until 23 December 2019)This list may be incomplete. See all names on Companies House
- Industry
- Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- Jay Charles Lecoque
- Owned by
- Accounts type
- Total exemption full
- Region
- East Midlands
- Address
- 1 Orchard PlaceNottingham Business ParkNottinghamNG8 6PX
Charges
- Total
- 15
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 14
Officers 2 active
Officer details are public data from the Companies House register.
Director · Appointed 10 April 2025
British
Born August 1973 (53)
Lecoque, Jay Charles
Director · Appointed 10 April 2025
American
Born November 1962
Officer history (28 former)
10 April 2025
Appointed Lecoque, Jay Charles as Director
10 April 2025
10 April 2025
20 February 2025
Resigned Cooke, Anthony, Dr. as Director
2 September 2020
18 July 2019
18 July 2019
18 July 2019
Appointed Cooke, Anthony, Dr. as Director
30 September 2014
Resigned Lowther, Susan Day as Secretary
30 September 2014
1 September 2014
13 July 2014
13 June 2014
13 June 2014
4 March 2014
3 May 2013
Resigned Deusch, Kai, Dr as Director
30 April 2013
14 April 2013
15 January 2013
31 December 2012
19 June 2011
4 August 2010
4 August 2010
Appointed Lowther, Susan Day as Secretary
3 August 2010
Resigned Kennedy, Madeleine Elizabeth as Secretary
3 August 2010
Resigned Kennedy, Madeleine Elizabeth as Director
16 March 2010
27 February 2009
Appointed Deusch, Kai, Dr as Director
22 December 2008
31 October 2008
31 January 2008
31 January 2008
Resigned Tyms, Albert Stanley, Dr as Director
29 January 2008
21 May 2007
21 May 2007
Appointed Kennedy, Madeleine Elizabeth as Director
21 May 2007
Appointed Kennedy, Madeleine Elizabeth as Secretary
19 September 2006
13 September 2006
12 September 2006
Resigned Daruvalla, Nigel as Secretary
24 May 2006
3 April 2006
3 April 2006
3 April 2006
Appointed Daruvalla, Nigel as Secretary
30 September 2005
31 May 2005
31 May 2005
31 May 2005
1 May 2005
22 April 2005
Appointed Tyms, Albert Stanley, Dr as Director
22 April 2005
22 April 2005
22 April 2005
22 April 2005
3 March 2005
3 March 2005
3 March 2005
3 March 2005
3 March 2005
3 March 2005
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 10 April 2025
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 14552442
Former controllers (2)
10 April 2025
Ceased Cambridge Pathology B.V. — Owns 75–100% of shares
18 July 2019
Ceased Novacyt S.A — Owns 75–100% of shares
Group structure 11 companies
Ownership group derived from the Companies House PSC register
Source Bioscience Limited Owns 75–100% of shares
Cryobank Guarantor Limited Owns 75–100% of shares
Fairfield Imaging Limited Owns 75–100% of shares
Ldpath Limited Owns 75–100% of shares
Select Pharma Laboratories Ltd. Owns 75–100% of shares
Source Bioscience (Orchard Place) Limited Owns 75–100% of shares
Source Bioscience UK Limited Owns 75–100% of shares
Source Genomics Limited Owns 75–100% of shares
Cambridge Clinical Laboratories Ltd This company Owns 75–100% of shares
Source Bioscience Nominees Limited Owns 75–100% of shares
Financials
Balance sheet as at 31 December 2024 · total exemption full accounts
- Net Assets
- (£1,438,775)
- Cash
- £1,343
- Employees
- 14
- Debt Ratio
- 467%
- Current Ratio
- 0.7x
Trend
Net Assets
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £89,551 | £258,537 | £210,186 | £248,266 | £176,376 | £33,645 |
| Current Assets | £302,284 | £421,451 | £435,223 | £943,016 | £724,306 | £229,229 |
| Debtors | £250,936 | £288,461 | £256,255 | £263,815 | £466,234 | £175,792 |
| Cash | £1,343 | £6,838 | £16,272 | £462,710 | £258,072 | £30,904 |
| Creditors (< 1 year) | £463,873 | £382,358 | £254,547 | £440,818 | £337,949 | £397,206 |
| Creditors (> 1 year) | £1,366,737 | £1,024,429 | £502,297 | £268,058 | £490,072 | |
| Net Current Assets | (£161,589) | £39,093 | £180,676 | £502,198 | £386,357 | (£167,977) |
| Net Assets | (£1,438,775) | (£726,799) | (£117,435) | £476,406 | £66,661 | (£140,332) |
| Shareholder Funds | (£726,799) | (£117,435) | £476,406 | £66,661 | (£140,332) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 5 November 2026 | Other filing | |||
| 22 June 2026 | Other filing | |||
| 22 June 2026 | Other filing | |||
| 28 May 2026 | Registration of a charge | |||
| 12 March 2026 | Confirmation statement with updates | 26 February 2026 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →